R J Hollis - JoVE Visualize

Showing results (61-70 of 113) with videos related to

Pageof 12

Sort By:

Diagnostic Microbiology and Infectious Disease|February 20, 2004

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsM A Pfaller, D J Diekema, S A Messer, et al.

Human Genetics|August 1, 1988

Breakage of the T cell receptor alpha chain locus in non malignant clones from patients with ataxia telangiectasiaA Heppell, S V Butterworth, R J Hollis, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999

Recurrent gram-negative bacteremia: incidence and clinical patternsC Wendt, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|January 9, 2003

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from bloodM A Pfaller, D J Diekema, S A Messer, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1994

Candida tropicalis vertebral osteomyelitis: a late sequela of fungemiaC Ferra, B N Doebbeling, R J Hollis, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999

Molecular epidemiology of gram-negative bacteremiaC Wendt, S A Messer, R J Hollis, et al.

Infection Control and Hospital Epidemiology|June 1, 1994

Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresisH S Sader, T M Perl, R J Hollis, et al.

Journal of Clinical Microbiology|December 17, 2010

Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilutionM A Pfaller, L Boyken, R J Hollis, et al.

Journal of Clinical Microbiology|August 7, 2009

Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller, S A Messer, R J Hollis, et al.

Archives of Internal Medicine|July 11, 1994

Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriageB N Doebbeling, D R Reagan, M A Pfaller, et al.

Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:

Pageof 12

Diagnostic Microbiology and Infectious Disease|February 20, 2004

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsM A Pfaller, D J Diekema, S A Messer, et al.

Human Genetics|August 1, 1988

Breakage of the T cell receptor alpha chain locus in non malignant clones from patients with ataxia telangiectasiaA Heppell, S V Butterworth, R J Hollis, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999

Recurrent gram-negative bacteremia: incidence and clinical patternsC Wendt, S A Messer, R J Hollis, et al.

Journal of Clinical Microbiology|January 9, 2003

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from bloodM A Pfaller, D J Diekema, S A Messer, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1994

Candida tropicalis vertebral osteomyelitis: a late sequela of fungemiaC Ferra, B N Doebbeling, R J Hollis, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999

Molecular epidemiology of gram-negative bacteremiaC Wendt, S A Messer, R J Hollis, et al.

Infection Control and Hospital Epidemiology|June 1, 1994

Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresisH S Sader, T M Perl, R J Hollis, et al.

Journal of Clinical Microbiology|December 17, 2010

Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilutionM A Pfaller, L Boyken, R J Hollis, et al.

Journal of Clinical Microbiology|August 7, 2009

Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller, S A Messer, R J Hollis, et al.

Archives of Internal Medicine|July 11, 1994

Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriageB N Doebbeling, D R Reagan, M A Pfaller, et al.

Pageof 12